— Know what they know.
Not Investment Advice

CARL NASDAQ

Carlsmed, Inc.
1W: +14.8% 1M: +3.2% 3M: -4.7% YTD: -2.9%
$11.72
+0.43 (+3.85%)
 
Weekly Expected Move ±9.5%
$9 $10 $11 $12 $13
NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Buy · Power 59 · $306.9M mcap · 10M float · 1.52% daily turnover · Short 42% of daily vol
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$306.9M
52W Range8.5-17.19
Volume475,255
Avg Volume150,837
Beta1.39
Dividend
Analyst Ratings
3 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOMichael John Cordonnier
Employees100
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2018-04-05
1800 Aston Avenue
Carlsbad, CA 92008
US
(760) 766-1923
About Carlsmed, Inc.

Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient. It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in Carlsbad, California.

Recent Insider Trades

NameTypeSharesPriceDate
Cordonnier Michael M-Exempt 33,264 $4.35 2026-03-03
Cordonnier Michael M-Exempt 33,264 $4.35 2026-03-03
Cordonnier Michael M-Exempt 160,567 $0.34 2026-03-03
Cordonnier Michael M-Exempt 160,567 $0.34 2026-03-03
Cordonnier Michael S-Sale 197,855 $13.29 2026-03-02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms